FindMyKOL

Nimish Shah, MD

Basic profile

Baystate Medical Center

ORCID↗NPI↗
✓ Itemized record
RegionNorthampton, MA · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLFindMyKOL type: RegionalLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Nimish Shah is a Cardiology physician affiliated with Baystate Medical Center. OpenAlex indexes 29 publications with 273 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
29publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

273citations

Citations across these publications.

6h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    86%
    Statin26%
    Rosuvastatin Calcium57%Atorvastatin Calcium43%
    Part D≥36 patients
    Beta blocker22.9%
    Metoprolol Succinate66%Carvedilol26%Metoprolol Tartrate8%
    Part D<11 patients

    + 9 more classes in this area

  • Blood & clotting

    11.6%
    Factor Xa inhibitor9%
    Eliquis100%
    Part D≥22 patients
    P2Y12 inhibitor2.6%
    Clopidogrel100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    2.5%
    SGLT2 inhibitor2.5%
    Farxiga100%
    Part D<11 patients
Where care is delivered (Part B)55.5% facility · 44.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”